Collectively, these results remind us that M2 macrophages increase SLC16A1-AS1 expression of HCC cells through METTL3-mediated m6A modification and IGF2BP3-dependent RNA stability. The gene discussed is IGF2BP3; the disease is hepatocellular carcinoma.